EMTA BRL Indicative Survey Rate definition

EMTA BRL Indicative Survey Rate means, in respect of any date, the USD/BRL foreign exchange rate for USD expressed as the amount of BRL per 1.00 USD, for settlement in two São Paulo and New York Business Days as published on EMTA's website (www.emta.org) at around 12:00 p.m. (São Paulo time) or as soon thereafter as practicable. EMTA BRL Indicative Survey Rate is calculated by EMTA (or a service provider EMTA may select in its sole discretion) pursuant to the EMTA BRL Indicative Survey Methodology (which means a methodology, dated as of 1 March, 2004, as amended from time to time, for a centralised industry-wide survey of financial institutions in Brazil that are active participants in the BRL/USD spot markets for the purpose of determining the EMTA BRL Indicative Survey Rate).
EMTA BRL Indicative Survey Rate or “BRL13” each means that the Spot Rate for a Rate Calculation Date will be the Brazilian Real/U.S. Dollar Specified Rate for U.S. Dollars, expressed as the amount of Brazilian Reais per one U.S. Dollar, for settlement in two Business Days, as published on EMTA’s web site (www.emta.org) at approximately 12:00 p.m. (São Paulo time), or as soon thereafter as practicable, on such Rate Calculation Date. The Spot Rate shall be calculated by EMTA (or a service provider EMTA may select in its sole discretion) pursuant to the EMTA BRL Indicative Survey Methodology (which means a methodology, dated as of March 1, 2004, as amended from time to time, for a centralized industry-wide survey of financial institutions that are active participants in the Brazilian Real/U.S. Dollar markets for the purpose of determining the EMTA BRL Indicative Survey Rate).
EMTA BRL Indicative Survey Rate means BRL/USD exchange rate for USD, expressed as the amount of BRL per one USD, for settlement in two Rio de Janeiro, Brasilia or Sao Paulo and New York Business Days, as published on EMTA’s web site (www.emta.org) at approximately 12:00 p.m. (Sao Paulo time), or as soon thereafter as practicable, on the BRL Valuation Date. The BRL Rate shall be calculated by EMTA (or a service provider EMTA may select in its sole discretion) pursuant to the EMTA BRL Indicative Survey Methodology (which means a methodology, dated as of March 1, 2004, as amended from time to time, for a centralized industry-wide survey of financial institutions that are active participants in the BRL/USD markets for the purpose of determining the EMTA BRL Indicative Survey Rate). The Company acknowledges that the Counterparty, acting directly or through a branch or an affiliate, may be requested to provide a quotation or quotations from time to time for the purpose of determining the EMTA BRL Indicative Survey Rate and such quotation may affect, materially or otherwise, the settlement of the Notes.

Examples of EMTA BRL Indicative Survey Rate in a sentence

  • Upon consultation with EMTA, Inc., the Clearing House shall determine if the expiring Brazilian real/U.S. dollar futures contract shall be cash settled using either the EMTA BRL Industry Survey Rate or EMTA BRL Indicative Survey Rate, or deferred for cash settlement to a subsequent day.

  • The EMTA BRL Industry Survey Rate Methodology and the EMTA BRL Indicative Survey Rate Methodology follow this chapter in an Interpretation.

  • All new construction of on-site sewage disposal systems in the Town shall conform to Standards for Sewage and Waste Disposal Systems as then established by the Suffolk County Department of Health Services.

  • The recommendations of the Francis Inquiry report into the failings at Mid- Staffordshire NHS Foundation Trust, together with the learning and recommendations of the Keogh review and Berwick report are now embedded within our plans and strategies to ensure the care we provide is safe, of the highest quality, and provides the best patient experience.That is why our six values will play an important role as we move forward.

  • The procedures for the EMTA BRL Industry Survey Rate and EMTA BRL Indicative Survey Rate are defined in the Interpretation to this chapter.However, in the event that the Exchange determines that the Clearing House is unable to determine a Final Settlement Price pursuant to any of the preceding sections and the Interpretation to this chapter, then Rule 812 shall apply to determine the Final Settlement Price.

  • The Secondary Rate shall be EMTA BRL Industry Survey Rate (BRL12), or EMTA BRL Indicative Survey Rate (BRL 13), as the case may be.

  • This fact shows that LSEs do not appear to be subject to market power in such a way as to make compliance with RA obligations impossible.

  • ANNEXES94Annex 1: Common European Framework for Languages94Annex 2: Performance Monitoring Plan Matrix95Annex 3: Progress on Indicator Targets (Quantitative Impact)97Annex 4: Performance Indicator Reference Sheets101Annex 5: Success Stories114 EXECUTIVE SUMMARYIn January 2005, the Government of Sudan and the Sudan People’s Liberation Movement signed the Comprehensive Peace Agreement (CPA), ending Africa’s longest civil war.

  • Upon consultation with EMTA, Inc., the Clearing House shall determine if the expiring Brazilian real/U.S. dollar futures contract shall be cash settled using either the EMTA BRL Industry Survey Rate or EMTA BRL Indicative Survey Rate, or deferred for cash settlement to a subsequent day.2. Procedures if EMTA Determines a Price Materiality Percentage is Met on a Futures Contract Termination Day.

  • The procedures for the EMTA BRL Industry Survey Rate and EMTA BRL Indicative Survey Rate are defined in the Interpretation to this chapter.However, in the event that the Exchange President determines that the Clearing House is unable to determine a Final Settlement Price pursuant to any of the preceding sections and the Interpretation to this chapter, then Rule 81225703 shall apply to determine the Final Settlement Price.525703.


More Definitions of EMTA BRL Indicative Survey Rate

EMTA BRL Indicative Survey Rate means, in respect of any date, the USD/BRL foreign exchange rate for USD expressed as the amount of BRL per 1.00 USD, for settlement in two São Paulo and New York Business Days as published on EMTA's
EMTA BRL Indicative Survey Rate or “BRL 13” means that the BRL/USD Spot Rate for a for a BRL Valuation Date will be the Brazilian Real/U.S. Dollar specified exchange rate for U.S. Dollars, expressed as the amount of Brazilian Reais per one U.S. Dollar, for settlement in two Valuation Business Days, as published on EMTA’s web site (www.emta.org) at approximately 12:00 p.m. (São Paulo time), or as soon thereafter as practicable, on such for a BRL Valuation Date. The BRL/USD Spot Rate shall be calculated by EMTA (or a service provider EMTA may select in its sole discretion) pursuant to the EMTA BRL Indicative Survey Methodology (which means a methodology, dated as of March 1, 2004, as amended from time to time, for a centralized industry-wide survey of financial institutions that are active participants in the Brazilian Real/U.S. Dollar markets for the purpose of determining the EMTA BRL Indicative Survey Rate). “EMTA BRL Industry Survey Rate” or “BRL 12” means that the BRL/USD Spot Rate for a BRL Valuation Date will be the Brazilian Real/U.S. Dollar specified exchange rate for U.S. Dollars, expressed as the amount of Brazilian Reais per one U.S. Dollar, for settlement in two Valuation Business Days, as published on EMTA’s web site (www.emta.org) at approximately 3:45 p.m. (São Paulo time), or as soon thereafter as practicable, on such BRL Valuation Date. The BRL/USD Spot Rate shall be calculated by EMTA (or a service provider EMTA may select in its sole discretion) pursuant to the EMTA BRL Industry Survey Methodology (which means a methodology, dated as of March 1, 2004, as amended from time to time, for a centralized industry-wide survey of financial institutions in Brazil that are active participants in the Brazilian Real/U.S. Dollar spot markets for the purpose of determining the EMTA BRL Industry Survey Rate). “Maximum Days of Postponement” means 30 calendar days. “Price Materiality” means, in respect of a BRL Valuation Date, that the EMTA BRL Industry Survey Rate is available on such date and that BRL09 differs from the EMTA BRL Industry Survey Rate or the EMTA BRL Indicative Survey Rate by more than 3 per cent, provided however, that if there are insufficient responses to the EMTA BRL Industry Survey or the EMTA BRL Indicative Survey on the BRL Valuation Date the PriceMateriality will also be deemed to have been met.

Related to EMTA BRL Indicative Survey Rate

  • Monitoring Indicator means a measure of HSP performance that may be monitored against provincial results or provincial targets, but for which no Performance Target is set;

  • Additional Indication means any indication other than the Initial Indication.

  • Approved clinical trial means a phase I, phase II, phase III, or phase IV clinical trial that is conducted in relation to the prevention, detection, or treatment of cancer or other life-threatening disease or Condition and is described in any of the following:

  • Direction-indicator lamp means the lamp used to indicate to other road-users that the driver intends to change direction to the right or to the left;

  • MSAA Indicator Technical Specifications document means, as the context requires, either or both of the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Indicator Technical Specifications November 5, 2018 Version 1.3” and the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Target and Corridor-Setting Guidelines” as they may be amended or replaced from time to time;

  • Design Criteria Package means concise, performance-oriented drawings or specifications for a public construction project. The purpose of the Design Criteria Package is to furnish sufficient information to permit Design-Build Firms to prepare a bid or a response to the District’s Request for Proposals, or to permit the District to enter into a negotiated Design- Build Contract. The Design Criteria Package must specify performance- based criteria for the public construction project, including the legal description of the site, survey information concerning the site, interior space requirements, material quality standards, schematic layouts and conceptual design criteria of the project, cost or budget estimates, design and construction schedules, site development requirements, provisions for utilities, stormwater retention and disposal, and parking requirements applicable to the project. Design Criteria Packages shall require firms to submit information regarding the qualifications, availability, and past work of the firms, including the partners and members thereof.

  • Phase III Clinical Trial means a human clinical trial in any country, the results of which could be used to establish safety and efficacy of a Product as a basis for an NDA or would otherwise satisfy requirements of 21 CFR 312.21(c), or its foreign equivalent.

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Phase 1 Clinical Trial means a human clinical trial of a Licensed Product that would satisfy the requirements of 21 C.F.R. 312.21(a) or corresponding foreign regulations.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Phase IV Clinical Trial means a Clinical Trial conducted after Regulatory Approval of the applicable Product has been obtained from an appropriate Regulatory Authority as a condition to, or for the maintenance of, any Regulatory Approval, including a trial that would satisfy the requirements of 21 C.F.R. 312.85, as may be amended, or the foreign equivalent thereof.

  • Phase 2 Clinical Trial means a human clinical trial of a product that would satisfy the requirements of U.S. 21 C.F.R. Part 312.21(b), as amended, and is intended to explore a variety of doses, dose response, and duration of effect, and to generate evidence of clinical safety and effectiveness for a particular Indication or Indications in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Phase III Study means a human clinical trial that is prospectively designed to demonstrate statistically whether a product is safe and effective for use in humans in a manner sufficient to obtain regulatory approval to market such product in patients having the disease or condition being studied as described in 21 C.F.R. § 312.21(c) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Categorical pretreatment standard or “Categorical Standard” means any regulation containing pollutant discharge limits promulgated by the U.S. EPA in accordance with Sections 307(b) and (c) of the Clean Water Act, 33 USC 1317, which apply to a specific category of Users and which appear in 40 CFR Chapter I, Subchapter N, Parts 405-471.